122 related articles for article (PubMed ID: 4914032)
1. [Effect of piposulfan (ancyte) in malignant lymphomas and solid tumors].
Kenis Y
Acta Clin Belg; 1968; 23(2):103-13. PubMed ID: 4914032
[No Abstract] [Full Text] [Related]
2. Effect of piposulfan (NSC-47774) on malignant lymphomas and solid tumors.
Kenis Y
Cancer Chemother Rep; 1968 Apr; 52(3):433-9. PubMed ID: 5244316
[No Abstract] [Full Text] [Related]
3. [Experiences with intense cytostatic therapy of malignant tumors].
Siering H; Reinhardt M
Arzneimittelforschung; 1968 Sep; 18(9):1182-91. PubMed ID: 4885374
[No Abstract] [Full Text] [Related]
4. Midwest cooperative group evaluation of piposulfan (A-20968) in cancer.
Nelson NA; Talley RW; Reed ML; Evans AM; Isaacs BL; Huffman P; Louis J
Clin Pharmacol Ther; 1967; 8(3):385-91. PubMed ID: 5338383
[No Abstract] [Full Text] [Related]
5. [Treatment of chronic myeloid leukemia and lymphoreticular sarcoma with piposulfan].
Schmidt M; Havemann K
Dtsch Med Wochenschr; 1970 May; 95(21):1166-70. PubMed ID: 4910386
[No Abstract] [Full Text] [Related]
6. Clinical results of treatment with E. coli L-asparaginase in adults with leukemia, lymphoma, and solid tumors.
Clarkson B; Krakoff I; Burchenal J; Karnofsky D; Golbey R; Dowling M; Oettgen H; Lipton A
Cancer; 1970 Feb; 25(2):279-305. PubMed ID: 4905154
[No Abstract] [Full Text] [Related]
7. [Results of cytostatic therapy of malignant hemoblastoses].
Stacher A
Wien Z Inn Med; 1966 Jan; 47(1):1-16. PubMed ID: 4962311
[No Abstract] [Full Text] [Related]
8. Antineoplastic and immunosuppressive drugs. II. Therapeutic uses.
Cridland MD
Drugs; 1972; 3(5):331-51. PubMed ID: 4347084
[No Abstract] [Full Text] [Related]
9. High-dose corticoid therapy in Hodgkin's disease and other lymphomas.
Hall TC; Choi OS; Abadi A; Krant MJ
Ann Intern Med; 1967 Jun; 66(6):1144-53. PubMed ID: 5338940
[No Abstract] [Full Text] [Related]
10. Chemotherapy of the lymphomas.
Lacher MJ
Med Times; 1970 May; 98(5):96-102. PubMed ID: 4911076
[No Abstract] [Full Text] [Related]
11. [Intermittent high-dosage cyclophosphamide therapy].
Sakalová A; Kvietková V; Lichý D; Sámel M
Bratisl Lek Listy; 1970 Mar; 53(3):329-32. PubMed ID: 4909013
[No Abstract] [Full Text] [Related]
12. [Personal experience on the chemotherapy of leukemias and hematosarcomas].
Mathé G; Schneider M; Schwarzenberg L; Cattan A; Amiel JL; Schlumberger JR
Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):245-54. PubMed ID: 4874537
[No Abstract] [Full Text] [Related]
13. [What is reliable in the therapy of hematologic diseases? I. Hemoblastosis and malignant lymphoproliferative diseases].
Havemann K; Schmidt M; Malchow H; Sodomann CP
Internist (Berl); 1970 Dec; 11(12):441-9. PubMed ID: 4993105
[No Abstract] [Full Text] [Related]
14. [New viewpoints for indication for radiologic treatment in leukoses and retikuloses].
Musshoff K
Strahlentherapie; 1968 Jun; 135(6):641-55. PubMed ID: 4878792
[No Abstract] [Full Text] [Related]
15. [On the effect of a cytostatic of the methylhydrazine group on malignant hemoblastomas].
Böhnel J; Stacher A
Wien Med Wochenschr; 1966 May; 116(21):468-71. PubMed ID: 4863533
[No Abstract] [Full Text] [Related]
16. [Therapeutic trials in various hematosarcomas with 4-demethylepipo=dophyllotoxin-beta D thenylidene glucoside (VM 26 or EPT)].
Mathé G; Schwarzenberg L; Pouillart P; Weiner R; Oldham R; Jasmin C; Rosenfeld ; Hayat M; Schneider M; Amiel JL; Céoara B; Steresco-Musset M; de Vassal F
Nouv Presse Med; 1974 Feb; 3(8):447-51. PubMed ID: 4595690
[No Abstract] [Full Text] [Related]
17. Simultaneous Presence of Follicular Lymphoma, Diffuse Large B-cell Lymphoma, and Hodgkin-like Lymphoma.
Papoudou-Bai A; Marinos L; Papathanasiou K; Kanavaros P; Kapsali E
Turk J Haematol; 2018 Nov; 35(4):308-309. PubMed ID: 30398157
[No Abstract] [Full Text] [Related]
18. [The stratification treatment that was based on a prognostic factor of malignant lymphoma].
Niitsu N
Nihon Rinsho; 2007 Jan; 65 Suppl 1():534-9. PubMed ID: 17476756
[No Abstract] [Full Text] [Related]
19. The treatment of chronic lymphocytic leukaemia and malignant lymphomas with dipine.
Cattaneo N; De Cataldo F; Pensabene A; Tiso R
Oncology; 1967; 21(1):61-71. PubMed ID: 4870984
[No Abstract] [Full Text] [Related]
20. Use of a methyl hydrazine derivative (natulan), especially in Hodgkin's disease.
Hansen MM; Hertz H; Videaek A
Acta Med Scand; 1966 Aug; 180(2):211-24. PubMed ID: 5329155
[No Abstract] [Full Text] [Related]
[Next] [New Search]
